The company that makes OxyContin, members of the Sackler family who own it and many groups that sued over its role in the ...

Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no longer fully protects the company’s owners, members of the Sackler families, from ...

OxyContin maker Purdue Pharma ‘s latest plan to settle thousands of lawsuits over the toll of opioids could soon move forward after every U.S. state involved agreed to it. A judge on Wednesday is ...

On Monday, the Supreme Court will take on one of its highest-profile bankruptcy cases in recent memory: Whether or not to approve OxyContin-maker Purdue Pharma's controversial agreement that would ...

Two members of the wealthy Sackler family who own OxyContin maker Purdue Pharma LP offered apologies on Thursday for the role the prescription painkiller has played in the deadly U.S. opioid epidemic ...

OxyContin maker Purdue Pharma urged a bankruptcy judge on Wednesday to approve a restructuring plan that includes a $7.4 ...

A $7.4 billion settlement was reached with Purdue Pharma and the Sackler family over their role in the opioid crisis. The Sacklers will give up ownership and pay up to $6.5 billion, with money going ...

Last year, Richard Sackler was awarded a patent for a version of buprenorphine, a drug that blocks opioid receptors, administered by mouth in a thin film. In March, the FDA fast tracked the company’s ...

How much did the Sackler family profit before it surrendered Purdue Pharma? The family put the maker of Oxycontin into bankruptcy, part of a settlement over the opioid crisis. But an audit now shows ...

Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no longer ...